Alliance for Regenerative Medicine’s Post

What's on the horizon for the CGT sector? Today, Alliance for Regenerative Medicine is publishing our Horizon Scan on Emerging Technologies, which was developed with Catalyst Healthcare Consulting, Inc. (Nancy Myers, Taryn Serman, Ph.D). Read the full white paper here: https://lnkd.in/eiAu9rjD #cellandgenetherapy #cgt #emergingtechnologies

Take a peek into a riveting report that illuminates revolutionary breakthroughs and emerging technologies, carving the path for the future of Cell and Gene Therapy! 🚀✨ https://lnkd.in/dmJRSBWc #GeneTherapyRevolution #FutureOfMedicine

Alliance for Regenerative Medicine and Catalyst Healthcare Consulting, Inc. just released the results of our horizon scan for emerging technologies in CGTs. The report lists 11 technologies (well, we aimed for 10, but ended up with ties 😉) with substantial untapped clinical potential, capable of shaping the future of the biotech industry over the next 10 years. If you, like me, enjoy reading about CGT science and how these drugs may challenge regulatory paradigms currently in place, you should check out the publication! https://lnkd.in/emCuMN2F

Check out the new white paper highlighting the top emerging technologies in Cell & Gene Therapy from Catalyst Healthcare Consulting, Inc. and Alliance for Regenerative Medicine.

🌟 At the Forefront of Innovation: CellSEP and the Future of Cell & Gene Therapy In an insightful piece by the Alliance for Regenerative Medicine, emerging technologies in cell and gene therapy are spotlighted, shining a light on a new era in medical treatments. At CellSEP, we're excited about the potential these innovations hold for revolutionizing healthcare. From advanced gene editing techniques to breakthroughs in cellular delivery systems, we're committed to incorporating these cutting-edge technologies into our services. Our dedication to innovation ensures we remain leaders in providing solutions that pave the way for transformative patient care. Join us in exploring how these advancements will shape the future of medicine. Together, we're building a healthier tomorrow. #CellSEPInnovation #FutureOfBiotech #CellAndGeneTherapy #BiotechLeaders #innovatingcellsolutions #enhancinglifesciences

📢 Unlocking Cell and Gene Therapy Potential: SmartLabs Revolutionize Manufacturing 🧪 The cell and gene therapy market is growing rapidly, but development and manufacturing are complex. 🌍 SmartLabs offers a solution by hosting drug discovery, development, and manufacturing facilities in one location. 💰 This reduces costs and resources needed for non-scientific services, allowing companies to focus on developing robust processes. 💡 SmartLabs' modular facilities are customizable and phase-compliant, making it easier to transition through the drug development journey. 👥 Clients have access to expertise and support, and they retain control over their manufacturing process and IP. 🔬 SmartLabs aims to accelerate scientific breakthroughs and adapt to the evolving life sciences industry. #BioprocessUpdates #cellandgenetherapy #laboratorysolutions #manufacturingsolutions #drugdevelopment #smartlabs #scientificservices #costreduction #expertiseandsupport #manufacturingprocess #IPcontrol #scientificbreakthroughs #lifesciencesindustry #drugdiscovery #modularfacilities #phasetransition ▷ Read the full article here: 📎 https://lnkd.in/dF84Pnm4

🔬✨ Exploring the world of cell & gene therapy supply chain design Ready to dive into the world of designing high-performance, risk-controlled, and scalable cell & gene supply chains with a digital twin? Following our first two articles on the subject, the latest installment of our series delves into the crucial aspect of determining the optimal manufacturing capacity for CGT! Knowing how many manufacturing units are needed to treat all patients quickly enough is not as simple as it may seem! Running the manufacturing plant at 100% capacity may not always be the best solution. Find out why in this article by Philippe Ducarme and explore some solutions that could benefit you 👉 https://bit.ly/3uZg9yd Stay tuned for the last part of the series that will be coming very soon on our blog. Trust us, you won't want to miss this! 💡💊 #supplychain #digitaltwins #celltherapies #genetherapies #innovation

Join our Cell and Gene Therapy (CGT) Virtual Event on March 20, featuring technology and process advancements in CGTs development. 👉 Register here to secure your spot! https://lnkd.in/eMZ2pPax Delivered through an interactive virtual platform, this event features over 3 hours of insightful sessions led by 7 expert scientists across the ecosystem. Our exciting topics include: • Large scale processing of mesenchymal stromal cells (MSC) and T cell immunotherapies • Integrated, cutting-edge solutions and process advancements that supports end-to-end workflow • Regulatory considerations in raw material selection from research through commericalisation • Analytical platforms to evaluate the quality, safety, and efficacy of cell-based products #celltherapy #genetherapy #cellandgenetherapy #manufacturing

Join our Cell and Gene Therapy (CGT) Virtual Event on March 20, featuring technology and process advancements in CGTs development. 👉 Register here to secure your spot! https://lnkd.in/eMZ2pPax Delivered through an interactive virtual platform, this event features over 3 hours of insightful sessions led by 7 expert scientists across the ecosystem. Our exciting topics include: • Large scale processing of mesenchymal stromal cells (MSC) and T cell immunotherapies • Integrated, cutting-edge solutions and process advancements that supports end-to-end workflow • Regulatory considerations in raw material selection from research through commericalisation • Analytical platforms to evaluate the quality, safety, and efficacy of cell-based products #celltherapy #genetherapy #cellandgenetherapy #manufacturing